You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

VM4-037

Showing 1 - 25 of 3,296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Trial in Guadalajara (Sodium Hyaluronate Ophthalmic 0.4% BID, Sodium Hyaluronate Ophthalmic 0.4% QID, Sodium Hyaluronate

Recruiting
  • Dry Eye
  • Sodium Hyaluronate Ophthalmic 0.4% BID
  • +2 more
  • Guadalajara, Jalisco, Mexico
    Instituto Jalisciense del Metabolismo, S.C.
Mar 23, 2022

SVT, Vagal Bradycardia Trial in Exeter (Supine VM VAD, Supine VAD manometer, Modified VM VAD)

Completed
Has Results
  • SVT
  • Vagal Bradycardia
  • Supine VM VAD
  • +3 more
  • Exeter, Devon, United Kingdom
    Royal Devon & Exeter NHS FT
Jun 9, 2021

Photorefractive Keratectomy, Corneal De-epithelialization Trial (Sodium Hyaluronate Ophthalmic 0.4%, Trehalose 3% / Sodium

Not yet recruiting
  • Photorefractive Keratectomy
  • Corneal De-epithelialization
  • Sodium Hyaluronate Ophthalmic 0.4%
  • Trehalose 3% / Sodium Hyaluronate Ophthalmic 0.15%
  • (no location specified)
Mar 23, 2022

Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Recruiting
  • Alzheimer's Disease
  • Santa Ana, California
  • +19 more
Aug 9, 2022

Psoriasis Trial in Kayseri (GN037, Placebo)

Active, not recruiting
  • Psoriasis
  • Kayseri, Turkey
    Erciyes University IKUM Center
Jul 26, 2022

Psoriasis Trial in Turkey (GN037, Clobetasol 17-Propionate Cream, Placebo)

Recruiting
  • Psoriasis
  • Ankara, Turkey
  • +11 more
Jan 23, 2023

Dry Eye Trial in Guadalajara (Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%, Sodium hyaluronate 0.15%, Sodium hyaluronate

Recruiting
  • Dry Eye
  • Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%
  • +2 more
  • Guadalajara, Jalisco, Mexico
    Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Dec 22, 2021

Gout Chronic, Hyperuricemia Trial in United States (SEL-212, SEL-037, SVP-rapamycin (SEL-110))

Completed
Has Results
  • Gout Chronic
  • Hyperuricemia
  • Anaheim, California
  • +12 more
Jan 31, 2022

Liver Transplant Rejection Trial in Worldwide (CFZ533, Tacrolimus - MMF - corticosteroids)

Active, not recruiting
  • Liver Transplant Rejection
  • CFZ533
  • Tacrolimus - MMF - corticosteroids
  • Los Angeles, California
  • +28 more
Jan 17, 2023

Enteral Nutrition, Critical Care, Feeding Methods Trial in Albacete (INTERMITTENT ENTERAL NUTRITITION (IEN), CONTINUOS ENTERAL

Recruiting
  • Enteral Nutrition
  • +3 more
  • INTERMITTENT ENTERAL NUTRITITION (IEN)
  • CONTINUOS ENTERAL NUTRITITION (CEN)
  • Albacete, Spain
    Maria Dolores Saiz Vinuesa
May 25, 2023

Huntington Disease Trial in Worldwide (Pridopidine, Placebo)

Active, not recruiting
  • Huntington Disease
  • Davis, California
  • +57 more
Dec 10, 2022

Post-Operative Wound Infection, Surgical Site Infection Trial in Annecy (Subcutaneous disinfection, Benzoyl peroxide

Not yet recruiting
  • Post-Operative Wound Infection
  • Surgical Site Infection
  • Subcutaneous disinfection
  • Benzoyl peroxide preparation
  • Annecy, France
    Clinique Générale d'Annecy
Jan 18, 2023

Critical Limb Ischemia Trial in Minneapolis (VM202 2mg, VM202 4mg, VM202 8mg)

Completed
  • Critical Limb Ischemia
  • VM202 2mg
  • +3 more
  • Minneapolis, Minnesota
    Minneapolis Heart Institute Foundation/ Abbott Northwestern Hosp
Oct 16, 2019

Chorea Associated With Huntington Disease Trial in Australia, Canada, United States (SD-809)

Completed
Has Results
  • Chorea Associated With Huntington Disease
  • Birmingham, Alabama
  • +37 more
Nov 5, 2021

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Aducanumab (BIIB037)
    • Placebo
    • Birmingham, Alabama
    • +179 more
    Aug 9, 2021

    Atrial Fibrillation (AF), Stroke Trial in Worldwide (Abelacimab, Rivaroxaban)

    Active, not recruiting
    • Atrial Fibrillation (AF)
    • Stroke
    • Huntsville, Alabama
    • +93 more
    Jan 25, 2023

    Food Allergy in Infants, Nut Allergy Trial in Melbourne (Home introduction, Multi Nut oral food challenge)

    Recruiting
    • Food Allergy in Infants
    • Nut Allergy
    • Home introduction
    • Multi Nut oral food challenge
    • Melbourne, Victoria, Australia
      Murdoch Children's Research Institute (MCRI)
    Dec 7, 2022

    Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Aducanumab (BIIB037)
    • Placebo
    • Phoenix, Arizona
    • +180 more
    Aug 9, 2021

    Inflammation and Pain Associated With Ocular Surgery Trial in United States (SDN-037, Placebo)

    Completed
    Has Results
    • Inflammation and Pain Associated With Ocular Surgery
    • Chandler, Arizona
    • +18 more
    May 14, 2021

    Amyotrophic Lateral Sclerosis Trial in Italy (Rapamycin, Placebo Oral Tablet)

    Completed
    • Amyotrophic Lateral Sclerosis
    • Genova, Italy
    • +7 more
    Aug 9, 2022

    Asthma in Children Trial (BACK-S, BACK-E)

    Not yet recruiting
    • Asthma in Children
    • BACK-S
    • BACK-E
    • (no location specified)
    Aug 14, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

    Terminated
    Has Results
    • Metastatic Castration-resistant Prostate Cancer
    • Avelumab
    • 2nd generation ADT (abiraterone or enzalutamide)
    • New Orleans, Louisiana
      Tulane University School of Medicine
    Apr 6, 2022

    Ischemic Stroke, Acute, Minocycline, Endovascular Treatment Trial (Minocycline)

    Not yet recruiting
    • Ischemic Stroke, Acute
    • +3 more
    • (no location specified)
    Aug 20, 2022

    Resistant Epilepsy, Drug, Adolescent Epilepsy, Children Epilepsy Trial in Petach Tikvah, Ljubljana (MGCND00EP1, Placebo, ECG)

    Not yet recruiting
    • Resistant Epilepsy, Drug
    • +3 more
    • Petach Tikvah, Central District, Israel
    • +1 more
    Aug 23, 2022